Tag: ASPN 2023
Biotronik announces new data supporting effectiveness of RESONANCE multiphase stimulation paradigm
Biotronik Neuro has announced that results from the BENEFIT-02 trial—the “first of its kind” to clinically evaluate a multiphase stimulation paradigm—support the effectiveness of...
Nalu presents new study data on pain management with PNS and...
Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal...
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
